Dreampath Diagnostics

Transaction overview

Status: Reported acquisition

Exact closing date not established.

Summit Partners reported that its portfolio company Dreampath Diagnostics had been acquired by Halma plc. Summit had made a growth investment in the anatomical-pathology workflow business in July 2025. The exact closing day was not stated.

Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.